Medicare Will Look To Informal Pathways For Faster Medtech Reimbursement
Executive Summary
The US Centers for Medicare and Medicaid Services has withdrawn efforts on a proposed rule to offer faster Medicare reimbursement to novel devices, but the agency still plans to work on different approaches to provide "timely patient access" to device innovations, a spokeswoman said. AdvaMed says it is disappointed by CMS's decision to withdraw the rule after a 10-month review by the Office of Management and Budget.
You may also be interested in...
CMS Actively Looking For New Reimbursement Pathway For Innovative Devices
Industry is looking for a policy by the end of the year that would provide an automatic, temporary coverage pathway for breakthrough devices, and federal officials, including from the US Centers for Medicare and Medicaid Services (CMS) acknowledge they are actively looking at options for improving device reimbursement.
'The Sky's The Limit' When It Comes To Device Reimbursement Reforms, White House Official Says
The top health official at the White House Office of Management and Budget says the Trump administration is committed to clearing barriers that stand in the way of reimbursement for new medical technology. “We’re doing a lot of work on medical device stuff that nobody knows about, trying to figure out how America can maintain our dominance," Joe Grogan said Sept. 20.
CMS Could Streamline Coverage For Breakthrough Medtech Under House Proposal
Newly introduced bill would seek to smooth the Medicare coverage and reimbursement pathway for breakthrough devices.